2012
Early Identification of HIV: Empirical Support for Jail-Based Screening
de Voux A, Spaulding AC, Beckwith C, Avery A, Williams C, Messina LC, Ball S, Altice FL. Early Identification of HIV: Empirical Support for Jail-Based Screening. PLOS ONE 2012, 7: e37603. PMID: 22662177, PMCID: PMC3360747, DOI: 10.1371/journal.pone.0037603.Peer-Reviewed Original ResearchConceptsAntiretroviral treatmentClient-level dataCD4 countHIV testingMedian CD4 countRoutine HIV testingInitial CD4 countTime of diagnosisInjection drug useYounger median ageUnprotected anal intercourseCross-sectional analysisAntiretroviral therapyMedian agePharmacy costsDisease progressionAnal intercoursePost dischargeSubset of individualsNew diagnosisDrug useEarly identificationDiagnosisCells/Baseline data
1999
Clinical Guidelines and Pharmacist Intervention Program for HIV‐Infected Patients Requiring Granulocyte Colony‐Stimulating Factor Therapy
Engles‐Horton L, Skowronski C, Mostashari F, Altice F. Clinical Guidelines and Pharmacist Intervention Program for HIV‐Infected Patients Requiring Granulocyte Colony‐Stimulating Factor Therapy. Pharmacotherapy The Journal Of Human Pharmacology And Drug Therapy 1999, 19: 356-362. PMID: 10221375, DOI: 10.1592/phco.19.4.356.30938.Peer-Reviewed Original ResearchConceptsIntervention periodPreintervention periodFactor therapyG-CSFGranulocyte colony-stimulating factor therapyHuman immunodeficiency virus (HIV) infectionColony-stimulating factor therapyPharmacist intervention programPharmacist-based interventionMean hospital stayImmunodeficiency virus infectionHospital medical information systemG-CSF dosesNumber of patientsMedical house staffTherapeutics subcommitteeHospital stayPharmacist interventionsChart reviewHospitalized patientsClinical pharmacistsImmunodeficiency syndromePatient morbidityPharmacy costsClinical guidelines